Systemic fungal infection · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs partially absorbed from GI tract (miconazole,… showed no clear difference in systemic fungal infection compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Systemic fungal infection · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole,… showed no clear difference in systemic fungal infection compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Proportion of participants with complete cure · children with tinea capitis
Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).
4 findings from 1 review
RR 1.06 [0.98, 1.15]
3 studies · 328 participants
Low
RR 1.18 [0.74, 1.88]
1 study · 1006 participants
Low
RR 0.68 [0.53, 0.86]
2 studies · 334 participants
Moderate
Show 1 more finding
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for ketoconazole showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).
2 findings from 1 review
Proportion of participants with complete cure · children with tinea capitis
Complete cure for fluconazole showed no clear difference in proportion of participants with complete cure compared with griseofulvin (moderate certainty).
2 findings from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for fluconazole showed no clear difference in the proportion of participants with complete cure compared with terbinafine (low certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for fluconazole showed no clear difference in proportion of participants with complete cure compared with itraconazole (low certainty).
1 finding from 1 review
Intervention not reported
Proportion of participants with complete cure · children infected with T. tonsurans and M. canis
The intervention showed no clear difference in proportion of participants with complete cure (low certainty).
1 finding from 1 review
Adverse events attributed to the study drugs · children with tinea capitis
Complete cure and adverse events for terbinafine showed no clear difference in adverse events attributed to the study drugs compared with griseofulvin (moderate certainty).
1 finding from 1 review
Severe adverse events · children with tinea capitis
Complete cure and adverse events for terbinafine showed no clear difference in severe adverse events compared with griseofulvin (moderate certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton and Microsporum
It is very uncertain whether complete cure for itraconazole changes proportion of participants with complete cure compared with griseofulvin (very low certainty).
1 finding from 1 review
Proportion of participants with complete cure · children infected with Trichophyton
Complete cure for itraconazole showed no clear difference in proportion of participants with complete cure compared with terbinafine (low certainty).
1 finding from 1 review